POTASSIUM CITRATE

POTASSIUM CITRATE was reported 5571 times

POTASSIUM CITRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPOCITRATURIA 7 0.1077
1 THERAPEUTIC DRUG MONITORING ANALYSIS NOT PERFORMED 15 0.0508
2 LITHOTRIPSY 5 0.0294
3 INTERSTITIAL GRANULOMATOUS DERMATITIS 5 0.0259
4 NASAL POLYPECTOMY 4 0.0252
5 HYPEROXALURIA 4 0.0233
6 ANAEMIA OF MALIGNANT DISEASE 6 0.0214
7 PENILE BURNING SENSATION 6 0.0211
8 PSEUDOPORPHYRIA 7 0.0205
9 BACTERIAL PYELONEPHRITIS 6 0.0179
10 PRODUCT RESIDUE PRESENT 94 0.0174
11 HYPERCALCIURIA 8 0.0163
12 URINE CALCIUM INCREASED 5 0.0159
13 LIP EROSION 11 0.0151
14 CALCULUS URINARY 22 0.0143
15 SYSTEMIC INFECTION 21 0.0127
16 FISTULA OF SMALL INTESTINE 5 0.0120
17 NEPHROCALCINOSIS 14 0.0118
18 RENAL STONE REMOVAL 6 0.0108
19 HYPERTONIC BLADDER 31 0.0107
20 WOUND DRAINAGE 8 0.0101
21 BLOOD HOMOCYSTEINE INCREASED 4 0.0093
22 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 13 0.0093
23 CONSCIOUSNESS FLUCTUATING 9 0.0086
24 RESPIRATORY TRACT HAEMORRHAGE 5 0.0084
25 OTITIS MEDIA ACUTE 6 0.0082
26 NECROTISING OESOPHAGITIS 4 0.0080
27 RENAL TUBULAR ACIDOSIS 17 0.0078
28 GENITAL BURNING SENSATION 6 0.0069
29 FANCONI SYNDROME ACQUIRED 11 0.0063
30 PRODUCT MONITORING ERROR 9 0.0062
31 REGURGITATION 21 0.0061
32 NEPHROLITHIASIS 279 0.0061
33 ATONIC SEIZURES 5 0.0058
34 URETEROLITHIASIS 6 0.0057
35 PRODUCT SOLUBILITY ABNORMAL 28 0.0055
36 VITAMIN B12 DEFICIENCY 22 0.0054
37 PROSTATE INFECTION 5 0.0052
38 CARDIAC FAILURE CHRONIC 21 0.0049
39 BLADDER DISCOMFORT 6 0.0048
40 PRE-EXISTING CONDITION IMPROVED 30 0.0048
41 CALCULUS BLADDER 6 0.0044
42 INCISION SITE PAIN 5 0.0043
43 AORTIC STENOSIS 14 0.0040
44 HYPERPARATHYROIDISM SECONDARY 10 0.0040
45 MEDICATION RESIDUE PRESENT 19 0.0040
46 HYPERPARATHYROIDISM 8 0.0039
47 MICROCYTIC ANAEMIA 8 0.0038
48 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 4 0.0038
49 CYSTITIS INTERSTITIAL 6 0.0037
50 ABSCESS INTESTINAL 8 0.0037
51 ESSENTIAL TREMOR 4 0.0036
52 CATHETER SITE DISCHARGE 4 0.0036
53 HEPATOSPLENOMEGALY 9 0.0035
54 SEBORRHOEIC KERATOSIS 5 0.0034
55 NEPHROGENIC ANAEMIA 15 0.0032
56 OSTEOMALACIA 5 0.0032
57 SACROILIITIS 6 0.0032
58 METABOLIC ALKALOSIS 5 0.0031
59 LYMPHADENITIS 7 0.0029
60 OROPHARYNGEAL DISCOMFORT 26 0.0029
61 PSEUDOMONAL SEPSIS 5 0.0029
62 INFUSION SITE DISCHARGE 5 0.0028
63 SLEEP DEFICIT 6 0.0028
64 CATAPLEXY 4 0.0028
65 BLOOD ELECTROLYTES DECREASED 4 0.0028
66 BLOOD URIC ACID INCREASED 16 0.0028
67 LACTOSE INTOLERANCE 7 0.0027
68 ESSENTIAL HYPERTENSION 5 0.0027
69 NEPHRECTOMY 4 0.0027
70 MIOSIS 21 0.0026
71 FLANK PAIN 24 0.0026
72 ONYCHOLYSIS 4 0.0026
73 HYPOGEUSIA 5 0.0025
74 GLYCOSYLATED HAEMOGLOBIN DECREASED 4 0.0025
75 IRON DEFICIENCY 11 0.0024
76 CHRONIC SINUSITIS 9 0.0024
77 MULTIPLE FRACTURES 39 0.0024
78 OESOPHAGEAL VARICES HAEMORRHAGE 5 0.0023
79 PAPILLARY THYROID CANCER 4 0.0023
80 NOSOCOMIAL INFECTION 5 0.0023
81 PARESIS 5 0.0022
82 SPINAL COLUMN INJURY 5 0.0022
83 ORAL DISORDER 16 0.0022
84 HYDRONEPHROSIS 16 0.0021
85 OESOPHAGEAL ULCER 8 0.0021
86 MOTION SICKNESS 4 0.0021
87 FAECES SOFT 15 0.0021
88 EARLY SATIETY 4 0.0021
89 PROSTATOMEGALY 8 0.0020
90 ATRIOVENTRICULAR BLOCK 15 0.0019
91 SPINAL OSTEOARTHRITIS 17 0.0019
92 URINE ODOUR ABNORMAL 11 0.0019
93 PROTEIN URINE PRESENT 9 0.0018
94 CHOLECYSTITIS INFECTIVE 5 0.0018
95 THERAPEUTIC AGENT TOXICITY 6 0.0018
96 BLOOD POTASSIUM DECREASED 54 0.0018
97 URINE ABNORMALITY 8 0.0018
98 FUNCTIONAL GASTROINTESTINAL DISORDER 6 0.0017
99 HAEMANGIOMA 4 0.0017
100 NECK SURGERY 4 0.0017
101 PRODUCT USE COMPLAINT 27 0.0017
102 PURPURA 15 0.0017
103 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 9 0.0017
104 MYELOFIBROSIS 5 0.0017
105 REBOUND ACID HYPERSECRETION 5 0.0017
106 BRONCHITIS CHRONIC 4 0.0016
107 UROSEPSIS 15 0.0016
108 CARTILAGE INJURY 4 0.0016
109 FOREIGN BODY IN THROAT 5 0.0016
110 INFUSION SITE PRURITUS 5 0.0016
111 KIDNEY INFECTION 31 0.0016
112 TRISMUS 8 0.0015
113 ACTINIC KERATOSIS 4 0.0015
114 NEUTROPENIC SEPSIS 11 0.0015
115 CHRONIC KIDNEY DISEASE 117 0.0015
116 EPIGASTRIC DISCOMFORT 6 0.0015
117 HEPATIC NEOPLASM 5 0.0015
118 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
119 NYSTAGMUS 8 0.0015
120 DYSURIA 55 0.0015
121 BLOOD SODIUM INCREASED 4 0.0015
122 BK VIRUS INFECTION 5 0.0015
123 TONGUE ULCERATION 5 0.0015
124 HYPERURICAEMIA 6 0.0015
125 TASTE DISORDER 29 0.0014
126 RENAL PAIN 15 0.0014
127 MACULOPATHY 5 0.0014
128 SHOULDER OPERATION 6 0.0014
129 ELECTROCARDIOGRAM ABNORMAL 11 0.0014
130 RENAL CYST 11 0.0014
131 LUMBAR SPINAL STENOSIS 4 0.0014
132 PROTEINURIA 26 0.0014
133 SPLENOMEGALY 16 0.0014
134 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
135 ERUCTATION 26 0.0013
136 SEASONAL ALLERGY 19 0.0013
137 MALABSORPTION 7 0.0013
138 SNORING 5 0.0013
139 NOCTURIA 16 0.0013
140 NERVE COMPRESSION 12 0.0013
141 RENAL FUNCTION TEST ABNORMAL 6 0.0013
142 MULTIPLE ALLERGIES 10 0.0013
143 SPINAL COLUMN STENOSIS 6 0.0013
144 PROSTATIC DISORDER 7 0.0013
145 ABDOMINAL ADHESIONS 4 0.0013
146 DIVERTICULUM 9 0.0013
147 ENTEROCOCCAL INFECTION 6 0.0012
148 CHOLECYSTITIS ACUTE 7 0.0012
149 PROSTATIC SPECIFIC ANTIGEN INCREASED 17 0.0012
150 BLOOD POTASSIUM INCREASED 20 0.0012
151 FACET JOINT SYNDROME 4 0.0012
152 PERIPHERAL VENOUS DISEASE 5 0.0012
153 GOITRE 5 0.0012
154 GLOMERULAR FILTRATION RATE DECREASED 15 0.0012
155 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
156 SLEEP APNOEA SYNDROME 23 0.0012
157 INCREASED TENDENCY TO BRUISE 11 0.0012
158 LEFT VENTRICULAR DYSFUNCTION 8 0.0012
159 AMMONIA INCREASED 6 0.0012
160 LUNG NEOPLASM 5 0.0012
161 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
162 CERVICAL VERTEBRAL FRACTURE 4 0.0012
163 FORMICATION 8 0.0011
164 HYPOKALAEMIA 53 0.0011
165 CAROTID ARTERY STENOSIS 4 0.0011
166 NAIL DISORDER 10 0.0011
167 DYSPHEMIA 5 0.0011
168 MENISCUS INJURY 7 0.0011
169 ELECTROLYTE IMBALANCE 13 0.0011
170 FACIAL BONES FRACTURE 4 0.0011
171 POST PROCEDURAL INFECTION 9 0.0011
172 CLOSTRIDIUM DIFFICILE INFECTION 24 0.0011
173 MAJOR DEPRESSION 8 0.0011
174 HYPERKERATOSIS 6 0.0011
175 SYNOVIAL CYST 5 0.0011
176 URINARY INCONTINENCE 32 0.0011
177 FEELING DRUNK 8 0.0011
178 INFUSION SITE ERYTHEMA 9 0.0011
179 SQUAMOUS CELL CARCINOMA 10 0.0011
180 AUTOIMMUNE THYROIDITIS 4 0.0011
181 PARANASAL SINUS DISCOMFORT 4 0.0011
182 VITAMIN D DECREASED 9 0.0011
183 PARANASAL SINUS HYPERSECRETION 4 0.0010
184 PHARYNGITIS 13 0.0010
185 POOR QUALITY PRODUCT ADMINISTERED 11 0.0010
186 BLOOD MAGNESIUM DECREASED 9 0.0010
187 LIMB OPERATION 5 0.0010
188 END STAGE RENAL DISEASE 19 0.0010
189 INCONTINENCE 11 0.0010
190 OESOPHAGEAL DISORDER 4 0.0010
191 NECK PAIN 58 0.0010
192 IMPAIRED GASTRIC EMPTYING 14 0.0010
193 POLYDIPSIA 4 0.0010
194 CYSTITIS 32 0.0010
195 HAEMOLYTIC ANAEMIA 9 0.0010
196 HYPOCALCAEMIA 19 0.0010
197 EXTRASYSTOLES 7 0.0010
198 FLUID INTAKE REDUCED 5 0.0010
199 FOREIGN BODY 4 0.0010
200 PRODUCT PHYSICAL ISSUE 20 0.0010
201 INGUINAL HERNIA 6 0.0010
202 PETIT MAL EPILEPSY 5 0.0010
203 NEUTROPHIL COUNT INCREASED 10 0.0010
204 ESCHERICHIA INFECTION 8 0.0010
205 CACHEXIA 5 0.0010
206 HYPERCALCAEMIA 12 0.0010
207 OLIGURIA 6 0.0010
208 INFUSION SITE EXTRAVASATION 6 0.0010
209 MICTURITION URGENCY 11 0.0010
210 DIARRHOEA HAEMORRHAGIC 9 0.0010
211 PARTIAL SEIZURES 5 0.0010
212 INFUSION SITE SWELLING 6 0.0010
213 HYPOPHOSPHATAEMIA 7 0.0009
214 WHITE BLOOD CELL COUNT ABNORMAL 6 0.0009
215 BALANCE DISORDER 81 0.0009
216 INTERVERTEBRAL DISC DISORDER 4 0.0009
217 COMPRESSION FRACTURE 5 0.0009
218 INFUSION SITE PAIN 12 0.0009
219 CARDIAC FLUTTER 6 0.0009
220 STRESS FRACTURE 5 0.0009
221 MUSCLE STRAIN 8 0.0009
222 HIP SURGERY 5 0.0009
223 SOMNAMBULISM 6 0.0009
224 ASPIRATION 10 0.0009
225 MELANOCYTIC NAEVUS 4 0.0009
226 BLOOD CALCIUM INCREASED 8 0.0009
227 NONSPECIFIC REACTION 5 0.0009
228 LOCALISED INFECTION 22 0.0009
229 ARTERIOSCLEROSIS CORONARY ARTERY 6 0.0009
230 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
231 CATHETERISATION CARDIAC 4 0.0009
232 CARDIAC FAILURE ACUTE 6 0.0009
233 HYPOALBUMINAEMIA 7 0.0009
234 BLOOD URINE PRESENT 17 0.0009
235 DEMENTIA 25 0.0009
236 SPINAL OPERATION 11 0.0009
237 GASTROINTESTINAL INFECTION 8 0.0009
238 GOUT 16 0.0009
239 ILEUS 11 0.0009
240 RESPIRATORY TRACT CONGESTION 14 0.0009
241 TRICUSPID VALVE INCOMPETENCE 7 0.0009
242 C-REACTIVE PROTEIN INCREASED 32 0.0009
243 EXOSTOSIS 8 0.0009
244 RESPIRATION ABNORMAL 6 0.0009
245 HAEMATOCHEZIA 48 0.0009
246 MUSCLE TWITCHING 20 0.0009
247 HAIR GROWTH ABNORMAL 6 0.0009
248 CONJUNCTIVITIS 16 0.0009
249 METABOLIC DISORDER 5 0.0009
250 RIGHT VENTRICULAR FAILURE 6 0.0009
251 URINARY TRACT INFECTION 146 0.0009
252 STEVENS-JOHNSON SYNDROME 19 0.0009
253 FEELING OF BODY TEMPERATURE CHANGE 5 0.0009
254 LYMPHOCYTE COUNT DECREASED 15 0.0008
255 LYMPHADENOPATHY 30 0.0008
256 HAND FRACTURE 6 0.0008
257 BLOOD IRON DECREASED 10 0.0008
258 ODYNOPHAGIA 5 0.0008
259 WRIST FRACTURE 10 0.0008
260 BASAL CELL CARCINOMA 13 0.0008
261 AFFECT LABILITY 8 0.0008
262 TONGUE DISORDER 6 0.0008
263 LEUKOCYTOSIS 15 0.0008
264 GENERAL PHYSICAL HEALTH DETERIORATION 95 0.0008
265 VITAMIN D DEFICIENCY 8 0.0008
266 HORMONE LEVEL ABNORMAL 4 0.0008
267 INCORRECT DOSAGE ADMINISTERED 4 0.0008
268 FOOT DEFORMITY 9 0.0008
269 PANCREATIC DISORDER 4 0.0008
270 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
271 HOSPICE CARE 8 0.0008
272 LIGAMENT SPRAIN 8 0.0008
273 HALLUCINATION, VISUAL 17 0.0008
274 DYSPEPSIA 79 0.0008
275 THERAPEUTIC RESPONSE UNEXPECTED 36 0.0008
276 HEPATIC ENZYME ABNORMAL 4 0.0008
277 URINE OUTPUT DECREASED 7 0.0008
278 RENAL IMPAIRMENT 67 0.0008
279 MITRAL VALVE INCOMPETENCE 9 0.0008
280 DEHYDRATION 106 0.0008
281 COORDINATION ABNORMAL 11 0.0008
282 TOOTH ABSCESS 8 0.0008
283 CARPAL TUNNEL SYNDROME 11 0.0008
284 FOREIGN BODY SENSATION IN EYES 5 0.0008
285 PROCEDURAL COMPLICATION 6 0.0008
286 INCREASED UPPER AIRWAY SECRETION 4 0.0008
287 FAILURE TO THRIVE 4 0.0008
288 HYPERKALAEMIA 27 0.0008
289 TOOTH INFECTION 10 0.0008
290 JOINT DISLOCATION 8 0.0008
291 OSTEOARTHRITIS 32 0.0008
292 HYPERLIPIDAEMIA 9 0.0008
293 RETCHING 16 0.0007
294 JOINT INJURY 16 0.0007
295 HEREDITARY ANGIOEDEMA 8 0.0007
296 FIBROMYALGIA 18 0.0007
297 LIMB INJURY 20 0.0007
298 BACK INJURY 8 0.0007
299 CYTOPENIA 9 0.0007
300 GASTROOESOPHAGEAL REFLUX DISEASE 59 0.0007
301 HYPERSOMNIA 21 0.0007
302 ABNORMAL FAECES 6 0.0007
303 CHOLELITHIASIS 24 0.0007
304 CROHN'S DISEASE 5 0.0007
305 THIRST 13 0.0007
306 DRY MOUTH 59 0.0007
307 ECONOMIC PROBLEM 11 0.0007
308 CHOKING SENSATION 4 0.0007
309 OSTEOPENIA 11 0.0007
310 BLOOD CREATININE INCREASED 47 0.0007
311 POLLAKIURIA 30 0.0007
312 HEART RATE ABNORMAL 4 0.0007
313 MASS 10 0.0007
314 UPPER RESPIRATORY TRACT INFECTION 33 0.0007
315 EAR INFECTION 19 0.0007
316 VITREOUS FLOATERS 7 0.0007
317 LYMPHOMA 11 0.0007
318 TRANSIENT ISCHAEMIC ATTACK 24 0.0007
319 LIMB DISCOMFORT 22 0.0007
320 MUSCULOSKELETAL PAIN 37 0.0007
321 HAEMATOCRIT DECREASED 14 0.0007
322 BRAIN INJURY 7 0.0007
323 CARDIAC MURMUR 6 0.0007
324 ENTEROCOLITIS 4 0.0007
325 PANIC REACTION 5 0.0007
326 ACUTE KIDNEY INJURY 106 0.0007
327 PYELONEPHRITIS 6 0.0007
328 VISUAL FIELD DEFECT 5 0.0007
329 OEDEMA PERIPHERAL 84 0.0007
330 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
331 SLUGGISHNESS 7 0.0007
332 EAR DISCOMFORT 7 0.0007
333 AGEUSIA 17 0.0007
334 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
335 DECREASED INTEREST 4 0.0007
336 BACTERAEMIA 8 0.0007
337 PLEURISY 4 0.0007
338 SWOLLEN TONGUE 21 0.0007
339 IMMUNODEFICIENCY 10 0.0007
340 CONTUSION 64 0.0007
341 RED BLOOD CELL COUNT DECREASED 19 0.0007
342 PLATELET COUNT ABNORMAL 4 0.0007
343 CORONARY ARTERY OCCLUSION 9 0.0007
344 ACIDOSIS 5 0.0007
345 INSURANCE ISSUE 10 0.0007
346 SKIN CANCER 14 0.0006
347 ANAEMIA 124 0.0006
348 DEVICE RELATED INFECTION 10 0.0006
349 INJECTION SITE EXTRAVASATION 8 0.0006
350 PIGMENTATION DISORDER 4 0.0006
351 HYPOMAGNESAEMIA 9 0.0006
352 CONCUSSION 5 0.0006
353 FULL BLOOD COUNT DECREASED 13 0.0006
354 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
355 SINUSITIS 66 0.0006
356 HAEMATURIA 22 0.0006
357 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
358 RENAL INJURY 19 0.0006
359 EYE PAIN 36 0.0006
360 BLEPHAROSPASM 4 0.0006
361 TOOTH FRACTURE 7 0.0006
362 FOOT FRACTURE 12 0.0006
363 GAIT DISTURBANCE 121 0.0006
364 ORTHOSTATIC HYPOTENSION 11 0.0006
365 BLOOD BILIRUBIN INCREASED 17 0.0006
366 GINGIVAL PAIN 5 0.0006
367 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
368 IMPAIRED QUALITY OF LIFE 9 0.0006
369 BLOOD PRESSURE FLUCTUATION 15 0.0006
370 NEPHROPATHY TOXIC 7 0.0006
371 FISTULA 7 0.0006
372 BLOOD TRIGLYCERIDES INCREASED 11 0.0006
373 BLOOD CALCIUM DECREASED 7 0.0006
374 HAEMOGLOBIN ABNORMAL 4 0.0006
375 CHROMATURIA 14 0.0006
376 RHINITIS 5 0.0006
377 STENT PLACEMENT 5 0.0006
378 STATUS EPILEPTICUS 7 0.0006
379 FALL 206 0.0006
380 EYE SWELLING 23 0.0006
381 FLATULENCE 35 0.0006
382 HAEMORRHOIDS 12 0.0006
383 SCAB 7 0.0006
384 PHARYNGEAL SWELLING 6 0.0006
385 POLYP 4 0.0006
386 POLYURIA 5 0.0006
387 KNEE OPERATION 6 0.0006
388 OSTEOPOROSIS 25 0.0006
389 SPINAL COMPRESSION FRACTURE 5 0.0006
390 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
391 BLOOD PRESSURE ABNORMAL 12 0.0006
392 HEMIPLEGIA 5 0.0006
393 PAIN IN JAW 17 0.0006
394 FAECES DISCOLOURED 13 0.0006
395 CHOLECYSTITIS CHRONIC 4 0.0006
396 SPINAL PAIN 7 0.0006
397 BLOOD UREA INCREASED 10 0.0006
398 BREAST MASS 4 0.0006
399 RENAL FAILURE 79 0.0006
400 OROPHARYNGEAL PAIN 55 0.0006
401 BRONCHIECTASIS 4 0.0006
402 SKIN PLAQUE 5 0.0006
403 DRUG LEVEL DECREASED 6 0.0006
404 MOTOR DYSFUNCTION 6 0.0006
405 TACHYPNOEA 8 0.0006
406 CARDIAC FAILURE 47 0.0006
407 MUSCLE RIGIDITY 7 0.0006
408 TACHYCARDIA 52 0.0006
409 PHOTOPHOBIA 11 0.0006
410 ABDOMINAL DISTENSION 61 0.0006
411 HEPATOTOXICITY 13 0.0006
412 NEPHROTIC SYNDROME 4 0.0006
413 ECCHYMOSIS 4 0.0006
414 CARDIAC OPERATION 5 0.0006
415 ONYCHOCLASIS 4 0.0006
416 MUSCULOSKELETAL DISCOMFORT 10 0.0006
417 JOINT EFFUSION 4 0.0006
418 SNEEZING 13 0.0006
419 GASTRIC ULCER 11 0.0006
420 DIVERTICULITIS 16 0.0006
421 PULMONARY HYPERTENSION 12 0.0006
422 ORAL DISCOMFORT 8 0.0006
423 WEIGHT FLUCTUATION 6 0.0006
424 EYE IRRITATION 33 0.0006
425 PRODUCT ODOUR ABNORMAL 6 0.0006
426 PLATELET COUNT DECREASED 61 0.0006
427 OEDEMA 31 0.0006
428 FUNGAL INFECTION 19 0.0006
429 KNEE ARTHROPLASTY 12 0.0006
430 MOUTH ULCERATION 12 0.0006
431 CARDIOMEGALY 7 0.0006
432 TUMOUR LYSIS SYNDROME 5 0.0006
433 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
434 PAPULE 4 0.0006
435 MUSCLE SPASMS 104 0.0006
436 LUNG INFILTRATION 5 0.0006
437 DYSKINESIA 23 0.0006
438 ULCER 9 0.0006
439 ATRIAL FIBRILLATION 55 0.0006
440 SCIATICA 9 0.0006
441 CONSTIPATION 123 0.0006
442 SURGERY 33 0.0006
443 BLOOD PRESSURE INCREASED 86 0.0006
444 BODY HEIGHT DECREASED 6 0.0006
445 SECRETION DISCHARGE 7 0.0006
446 INFLUENZA LIKE ILLNESS 46 0.0006
447 RENAL DISORDER 26 0.0006
448 PRODUCT SUBSTITUTION ISSUE 32 0.0006
449 DISORIENTATION 22 0.0006
450 PHARYNGITIS STREPTOCOCCAL 6 0.0006
451 COMPLICATION ASSOCIATED WITH DEVICE 8 0.0006
452 LIP DRY 5 0.0005
453 PULMONARY THROMBOSIS 6 0.0005
454 ROAD TRAFFIC ACCIDENT 23 0.0005
455 GASTROENTERITIS 8 0.0005
456 DYSSTASIA 16 0.0005
457 SEPSIS 61 0.0005
458 DECREASED APPETITE 127 0.0005
459 ABDOMINAL PAIN 127 0.0005
460 INFECTION 79 0.0005
461 STAPHYLOCOCCAL INFECTION 18 0.0005
462 INJECTION SITE NODULE 6 0.0005
463 TINNITUS 25 0.0005
464 PSORIATIC ARTHROPATHY 22 0.0005
465 COVID-19 95 0.0005
466 CARDIOMYOPATHY 8 0.0005
467 DISCOMFORT 33 0.0005
468 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
469 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
470 NERVE INJURY 6 0.0005
471 FEELING COLD 15 0.0005
472 HEAD INJURY 17 0.0005
473 HEPATIC STEATOSIS 10 0.0005
474 APPENDICITIS 5 0.0005
475 THROAT IRRITATION 24 0.0005
476 HYPONATRAEMIA 30 0.0005
477 HEPATIC CIRRHOSIS 10 0.0005
478 LACERATION 5 0.0005
479 EYE INFECTION 6 0.0005
480 DYSARTHRIA 20 0.0005
481 ARTERIOSCLEROSIS 5 0.0005
482 INTESTINAL OBSTRUCTION 20 0.0005
483 BLOOD SODIUM DECREASED 10 0.0005
484 DIARRHOEA 340 0.0005
485 CONFUSIONAL STATE 85 0.0005
486 HAEMOGLOBIN DECREASED 54 0.0005
487 PLEURAL EFFUSION 32 0.0005
488 PERIPHERAL SWELLING 81 0.0005
489 CHOLECYSTECTOMY 6 0.0005
490 LIPASE INCREASED 4 0.0005
491 WHITE BLOOD CELL COUNT INCREASED 20 0.0005
492 ACUTE RESPIRATORY FAILURE 10 0.0005
493 DIFFUSE LARGE B-CELL LYMPHOMA 4 0.0005
494 FOOD ALLERGY 4 0.0005
495 HOT FLUSH 39 0.0005
496 TENDONITIS 8 0.0005
497 RASH PRURITIC 28 0.0005
498 DYSPHAGIA 49 0.0005
499 POST PROCEDURAL HAEMORRHAGE 6 0.0005
500 EAR PAIN 10 0.0005
501 PELVIC FRACTURE 4 0.0005
502 ASTHMA 58 0.0005
503 HAEMATEMESIS 13 0.0005
504 PALPITATIONS 60 0.0005
505 WEIGHT DECREASED 143 0.0005
506 CHILLS 60 0.0005
507 RENAL TUBULAR NECROSIS 5 0.0005
508 CYANOSIS 8 0.0005
509 THERAPY CHANGE 5 0.0005
510 HYPOTENSION 102 0.0005
511 COVID-19 PNEUMONIA 6 0.0005
512 FEELING HOT 31 0.0005
513 PRODUCT DISPENSING ERROR 11 0.0005
514 FURUNCLE 4 0.0005
515 BLOOD ALBUMIN DECREASED 4 0.0005
516 BLADDER DISORDER 5 0.0005
517 PAIN 309 0.0005
518 DRY EYE 25 0.0005
519 PNEUMONIA 162 0.0005
520 METABOLIC ACIDOSIS 16 0.0005
521 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 24 0.0005
522 BACK PAIN 116 0.0005
523 WHITE BLOOD CELL COUNT DECREASED 54 0.0005
524 DYSGEUSIA 37 0.0005
525 DIZZINESS 248 0.0005
526 PELVIC PAIN 9 0.0005
527 RHINORRHOEA 32 0.0005
528 ANHEDONIA 13 0.0005
529 GASTRITIS 13 0.0005
530 MUSCLE DISORDER 4 0.0005
531 BONE DISORDER 9 0.0005
532 BLOOD CHOLESTEROL INCREASED 23 0.0005
533 INFLUENZA 55 0.0005
534 THROMBOCYTOPENIA 55 0.0005
535 DRUG INTERACTION 78 0.0005
536 INTENTIONAL DOSE OMISSION 14 0.0005
537 CONDITION AGGRAVATED 149 0.0005
538 MUSCLE SPASTICITY 6 0.0005
539 HYPERAESTHESIA 4 0.0005
540 HEART RATE IRREGULAR 11 0.0005
541 RIB FRACTURE 10 0.0005
542 FATIGUE 378 0.0005
543 CYST 6 0.0005
544 ARTHRITIS 38 0.0005
545 EYE DISCHARGE 5 0.0005
546 NEEDLE ISSUE 14 0.0005
547 EOSINOPHIL COUNT INCREASED 4 0.0005
548 URINARY RETENTION 16 0.0005
549 DYSPHONIA 28 0.0005
550 FULL BLOOD COUNT ABNORMAL 5 0.0005
551 INCREASED APPETITE 9 0.0005
552 BREAST PAIN 5 0.0005
553 POST PROCEDURAL COMPLICATION 9 0.0005
554 PROCEDURAL PAIN 13 0.0005
555 ROTATOR CUFF SYNDROME 6 0.0005
556 PRODUCT CONTAINER ISSUE 4 0.0005
557 RECTAL HAEMORRHAGE 20 0.0005
558 NIGHT SWEATS 15 0.0005
559 ABDOMINAL DISCOMFORT 78 0.0005
560 HIATUS HERNIA 6 0.0005
561 BLISTER 26 0.0005
562 HYPERTENSION 98 0.0005
563 NEUROPATHY PERIPHERAL 44 0.0005
564 INCORRECT PRODUCT ADMINISTRATION DURATION 10 0.0005
565 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
566 RESPIRATORY TRACT INFECTION 12 0.0005
567 SKIN LACERATION 5 0.0005
568 BRONCHITIS 34 0.0005
569 CHEST DISCOMFORT 47 0.0005
570 CHEST PAIN 85 0.0005
571 SPEECH DISORDER 24 0.0005
572 DRUG DISPENSING ERROR 7 0.0005
573 MUSCULAR WEAKNESS 52 0.0005
574 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
575 JOINT STIFFNESS 12 0.0005
576 SKIN DISCOLOURATION 21 0.0005
577 BURNING SENSATION 32 0.0005
578 HEART RATE DECREASED 16 0.0005
579 PULMONARY CONGESTION 6 0.0005
580 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
581 GASTROINTESTINAL PAIN 5 0.0005
582 SINUS DISORDER 9 0.0005
583 MELAENA 10 0.0005
584 HEART RATE INCREASED 45 0.0005
585 COLD SWEAT 8 0.0005
586 IMMUNOSUPPRESSION 4 0.0005
587 ANKLE FRACTURE 7 0.0005
588 DENTAL CARIES 5 0.0005
589 DYSPNOEA EXERTIONAL 17 0.0005
590 DELUSION 7 0.0005
591 LUNG INFECTION 7 0.0005
592 GALLBLADDER DISORDER 8 0.0004
593 BRAIN FOG 7 0.0004
594 ORAL PAIN 10 0.0004
595 TREMOR 74 0.0004
596 MYOSITIS 4 0.0004
597 COUGH 125 0.0004
598 TYPE 2 DIABETES MELLITUS 15 0.0004
599 PARAESTHESIA 70 0.0004
600 PANCREATITIS ACUTE 10 0.0004
601 ANAL INCONTINENCE 4 0.0004
602 SINUS CONGESTION 6 0.0004
603 GASTROENTERITIS VIRAL 8 0.0004
604 VERTIGO 27 0.0004
605 FEELING ABNORMAL 106 0.0004
606 OSTEOMYELITIS 8 0.0004
607 SEIZURE 51 0.0004
608 BODY TEMPERATURE INCREASED 9 0.0004
609 MIGRAINE 42 0.0004
610 RESTLESS LEGS SYNDROME 8 0.0004
611 GINGIVAL BLEEDING 6 0.0004
612 OBESITY 7 0.0004
613 HYPERSENSITIVITY 81 0.0004
614 MYOCARDITIS 5 0.0004
615 ASTHENIA 164 0.0004
616 PNEUMONIA BACTERIAL 4 0.0004
617 GASTROINTESTINAL HAEMORRHAGE 36 0.0004
618 BACK DISORDER 7 0.0004
619 NAUSEA 340 0.0004
620 SWELLING 40 0.0004
621 ILLNESS 44 0.0004
622 RASH GENERALISED 11 0.0004
623 DIPLOPIA 11 0.0004
624 MYALGIA 72 0.0004
625 MUSCULOSKELETAL STIFFNESS 37 0.0004
626 TREATMENT NONCOMPLIANCE 23 0.0004
627 IRRITABLE BOWEL SYNDROME 9 0.0004
628 PARALYSIS 6 0.0004
629 SUBDURAL HAEMATOMA 6 0.0004
630 PYREXIA 145 0.0004
631 MOBILITY DECREASED 30 0.0004
632 NEUTROPHIL COUNT DECREASED 17 0.0004
633 PRURITUS GENERALISED 9 0.0004
634 DEPRESSED MOOD 22 0.0004
635 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
636 HYPOKINESIA 6 0.0004
637 INSOMNIA 110 0.0004
638 ADRENAL INSUFFICIENCY 5 0.0004
639 PRESYNCOPE 10 0.0004
640 NEURALGIA 10 0.0004
641 SCAR 7 0.0004
642 COELIAC DISEASE 4 0.0004
643 COGNITIVE DISORDER 19 0.0004
644 DYSPNOEA 230 0.0004
645 SMALL INTESTINAL OBSTRUCTION 5 0.0004
646 HIP FRACTURE 13 0.0004
647 CATARACT 24 0.0004
648 PULMONARY MASS 6 0.0004
649 NASOPHARYNGITIS 74 0.0004
650 EPISTAXIS 30 0.0004
651 HYPOTONIA 4 0.0004
652 PAIN IN EXTREMITY 118 0.0004
653 OCULAR HYPERAEMIA 19 0.0004
654 PEMPHIGUS 5 0.0004
655 BONE LOSS 6 0.0004
656 CELLULITIS 20 0.0004
657 UNEVALUABLE EVENT 30 0.0004
658 CORONARY ARTERY DISEASE 12 0.0004
659 GLYCOSYLATED HAEMOGLOBIN INCREASED 10 0.0004
660 IMPAIRED HEALING 13 0.0004
661 PRODUCT ADMINISTRATION ERROR 8 0.0004
662 VOMITING 186 0.0004
663 PRURITUS 152 0.0004
664 ABDOMINAL PAIN LOWER 10 0.0004
665 EYE DISORDER 13 0.0004
666 FEEDING DISORDER 8 0.0004
667 HYPOAESTHESIA 59 0.0004
668 HIP ARTHROPLASTY 6 0.0004
669 NASAL CONGESTION 23 0.0004
670 BLOOD PRESSURE DECREASED 26 0.0004
671 VIRAL INFECTION 13 0.0004
672 LIP SWELLING 13 0.0004
673 PRODUCT DOSE OMISSION ISSUE 114 0.0004
674 MUSCULOSKELETAL CHEST PAIN 6 0.0004
675 EJECTION FRACTION DECREASED 6 0.0004
676 NODULE 5 0.0004
677 ACCIDENTAL OVERDOSE 14 0.0004
678 THERAPEUTIC PRODUCT EFFECT DECREASED 17 0.0004
679 SARS-COV-2 TEST POSITIVE 5 0.0004
680 RASH ERYTHEMATOUS 18 0.0004
681 MOOD SWINGS 12 0.0004
682 THINKING ABNORMAL 7 0.0004
683 ARTHRALGIA 156 0.0004
684 IMPAIRED WORK ABILITY 8 0.0004
685 FLUSHING 38 0.0004
686 CARDIAC FAILURE CONGESTIVE 30 0.0004
687 MALIGNANT MELANOMA 5 0.0004
688 LABORATORY TEST ABNORMAL 11 0.0004
689 POOR QUALITY SLEEP 8 0.0004
690 DECREASED ACTIVITY 4 0.0004
691 RESPIRATORY FAILURE 27 0.0004
692 FREQUENT BOWEL MOVEMENTS 10 0.0004
693 SWELLING FACE 24 0.0004
694 PALLOR 10 0.0004
695 FEELING JITTERY 7 0.0004
696 DIABETES MELLITUS 28 0.0004
697 HEPATIC ENZYME INCREASED 25 0.0004
698 WEIGHT INCREASED 82 0.0004
699 METASTASES TO BONE 6 0.0004
700 HYPERHIDROSIS 47 0.0004
701 LOWER LIMB FRACTURE 7 0.0004
702 PERIPHERAL COLDNESS 5 0.0004
703 VENTRICULAR TACHYCARDIA 6 0.0004
704 STOMATITIS 22 0.0004
705 SOMNOLENCE 73 0.0004
706 HERNIA 7 0.0004
707 MENTAL STATUS CHANGES 10 0.0004
708 GAIT INABILITY 12 0.0004
709 LOSS OF CONSCIOUSNESS 46 0.0004
710 ARRHYTHMIA 17 0.0004
711 HUNGER 5 0.0004
712 HALLUCINATION 27 0.0004
713 MALNUTRITION 4 0.0004
714 PANIC ATTACK 13 0.0004
715 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
716 PRODUCTIVE COUGH 17 0.0004
717 CANDIDA INFECTION 6 0.0004
718 FLUID RETENTION 18 0.0004
719 RENAL FAILURE ACUTE 15 0.0004
720 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
721 CIRCULATORY COLLAPSE 6 0.0004
722 DEPRESSION 80 0.0004
723 UPPER LIMB FRACTURE 7 0.0004
724 BONE DENSITY DECREASED 11 0.0004
725 PRESCRIBED UNDERDOSE 7 0.0004
726 DERMATITIS CONTACT 4 0.0004
727 DRUG INEFFECTIVE 462 0.0004
728 SYNCOPE 35 0.0003
729 SPINAL FRACTURE 7 0.0003
730 CYTOKINE RELEASE SYNDROME 7 0.0003
731 UNRESPONSIVE TO STIMULI 9 0.0003
732 HERPES ZOSTER 20 0.0003
733 HEADACHE 218 0.0003
734 INFUSION RELATED REACTION 23 0.0003
735 PARAESTHESIA ORAL 5 0.0003
736 METASTASES TO LUNG 4 0.0003
737 DRUG DOSE OMISSION 57 0.0003
738 MADAROSIS 4 0.0003
739 INJECTION SITE HAEMATOMA 5 0.0003
740 HYPOTHYROIDISM 11 0.0003
741 INTENTIONAL PRODUCT MISUSE 30 0.0003
742 METASTASES TO LIVER 6 0.0003
743 SKIN HAEMORRHAGE 5 0.0003
744 ATAXIA 4 0.0003
745 DISEASE RECURRENCE 16 0.0003
746 MACULAR DEGENERATION 4 0.0003
747 RASH 146 0.0003
748 URTICARIA 56 0.0003
749 DISTURBANCE IN ATTENTION 18 0.0003
750 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 60 0.0003
751 LACRIMATION INCREASED 10 0.0003
752 ANXIETY 94 0.0003
753 BURSITIS 4 0.0003
754 EATING DISORDER 7 0.0003
755 VISION BLURRED 45 0.0003
756 INJECTION SITE MASS 12 0.0003
757 THROMBOSIS 26 0.0003
758 GENERALISED OEDEMA 4 0.0003
759 FEMUR FRACTURE 10 0.0003
760 INJECTION SITE DISCOLOURATION 4 0.0003
761 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
762 DRUG-INDUCED LIVER INJURY 10 0.0003
763 SICKLE CELL ANAEMIA WITH CRISIS 5 0.0003
764 COLITIS 12 0.0003
765 MUSCLE ATROPHY 4 0.0003
766 ANGINA PECTORIS 9 0.0003
767 ABSCESS 5 0.0003
768 HYPOPHAGIA 8 0.0003
769 GASTROINTESTINAL DISORDER 28 0.0003
770 SENSORY DISTURBANCE 5 0.0003
771 MOVEMENT DISORDER 10 0.0003
772 OFF LABEL USE 272 0.0003
773 ALOPECIA 61 0.0003
774 PRESCRIBED OVERDOSE 6 0.0003
775 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
776 DYSTONIA 6 0.0003
777 MUSCLE TIGHTNESS 5 0.0003
778 THERAPY INTERRUPTED 22 0.0003
779 BLOOD GLUCOSE INCREASED 58 0.0003
780 CHOKING 6 0.0003
781 PRODUCT AVAILABILITY ISSUE 7 0.0003
782 AMNESIA 20 0.0003
783 ORAL HERPES 6 0.0003
784 SKIN FISSURES 6 0.0003
785 DEAFNESS 8 0.0003
786 MALAISE 134 0.0003
787 SEDATION 8 0.0003
788 SHOCK 7 0.0003
789 BEDRIDDEN 4 0.0003
790 ANKYLOSING SPONDYLITIS 4 0.0003
791 LEUKOPENIA 15 0.0003
792 DEVICE MALFUNCTION 21 0.0003
793 SEPTIC SHOCK 13 0.0003
794 JOINT RANGE OF MOTION DECREASED 4 0.0003
795 FACE OEDEMA 5 0.0003
796 THROAT TIGHTNESS 8 0.0003
797 LETHARGY 17 0.0003
798 SKIN LESION 8 0.0003
799 BLOOD GLUCOSE DECREASED 14 0.0003
800 INFLAMMATION 15 0.0003
801 VISUAL IMPAIRMENT 36 0.0003
802 BONE PAIN 17 0.0003
803 RESPIRATORY DISTRESS 8 0.0003
804 INCORRECT DOSE ADMINISTERED 66 0.0003
805 DELIRIUM 10 0.0003
806 HAEMOPTYSIS 8 0.0003
807 WHEEZING 17 0.0003
808 INTENTIONAL PRODUCT USE ISSUE 25 0.0003
809 PANCREATITIS 15 0.0003
810 SKIN IRRITATION 13 0.0003
811 BLINDNESS UNILATERAL 4 0.0003
812 SLEEP DISORDER 20 0.0003
813 OSTEONECROSIS OF JAW 7 0.0003
814 BRADYCARDIA 15 0.0003
815 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
816 DRUG ERUPTION 5 0.0003
817 PLASMA CELL MYELOMA 11 0.0003
818 AGGRESSION 14 0.0003
819 DRUG INTOLERANCE 27 0.0003
820 LIVER FUNCTION TEST INCREASED 6 0.0003
821 HYPOACUSIS 12 0.0003
822 PRODUCT USE ISSUE 52 0.0003
823 MEMORY IMPAIRMENT 38 0.0003
824 PSORIASIS 36 0.0003
825 CRYING 10 0.0003
826 COMA 13 0.0003
827 THERAPY CESSATION 14 0.0003
828 ABDOMINAL PAIN UPPER 56 0.0003
829 THERAPEUTIC RESPONSE SHORTENED 9 0.0003
830 SKIN ULCER 7 0.0003
831 LIVER DISORDER 12 0.0003
832 BLINDNESS 11 0.0003
833 TOOTH DISORDER 6 0.0003
834 PANCYTOPENIA 15 0.0003
835 BACTERIAL INFECTION 5 0.0003
836 EYE PRURITUS 9 0.0003
837 RASH PAPULAR 6 0.0003
838 HAEMORRHAGE INTRACRANIAL 4 0.0003
839 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 19 0.0003
840 INCORRECT DOSE ADMINISTERED BY DEVICE 7 0.0003
841 OXYGEN SATURATION DECREASED 15 0.0003
842 HYPOAESTHESIA ORAL 4 0.0003
843 FRACTURE 5 0.0003
844 MYOCARDIAL INFARCTION 46 0.0003
845 INJECTION SITE RASH 8 0.0003
846 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
847 GLAUCOMA 5 0.0003
848 PERICARDIAL EFFUSION 6 0.0003
849 RASH MACULAR 9 0.0003
850 MOOD ALTERED 7 0.0003
851 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
852 HYPOXIA 9 0.0003
853 NEOPLASM MALIGNANT 17 0.0003
854 ABNORMAL DREAMS 7 0.0003
855 VAGINAL HAEMORRHAGE 11 0.0003
856 PULMONARY EMBOLISM 24 0.0003
857 PNEUMOTHORAX 4 0.0003
858 PRODUCT PRESCRIBING ERROR 6 0.0003
859 ARTHROPATHY 14 0.0003
860 SUICIDAL IDEATION 23 0.0003
861 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
862 HYPERGLYCAEMIA 9 0.0002
863 RHEUMATOID ARTHRITIS 28 0.0002
864 DEEP VEIN THROMBOSIS 16 0.0002
865 PULMONARY OEDEMA 11 0.0002
866 ENCEPHALOPATHY 6 0.0002
867 ERYTHEMA 50 0.0002
868 INJURY 17 0.0002
869 VISUAL ACUITY REDUCED 8 0.0002
870 HOSPITALISATION 37 0.0002
871 JOINT SWELLING 29 0.0002
872 ASCITES 7 0.0002
873 INJECTION SITE HAEMORRHAGE 19 0.0002
874 HEMIPARESIS 4 0.0002
875 PRODUCT QUALITY ISSUE 32 0.0002
876 HEPATITIS 6 0.0002
877 DEVICE ISSUE 21 0.0002
878 RESPIRATORY DISORDER 7 0.0002
879 APHASIA 7 0.0002
880 HAEMATOMA 6 0.0002
881 EMOTIONAL DISTRESS 28 0.0002
882 NIGHTMARE 8 0.0002
883 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
884 ILL-DEFINED DISORDER 14 0.0002
885 PRODUCT USE IN UNAPPROVED INDICATION 57 0.0002
886 MENTAL DISORDER 10 0.0002
887 PRODUCT DOSE OMISSION 15 0.0002
888 LOCAL SWELLING 4 0.0002
889 CONVULSION 13 0.0002
890 SKIN EXFOLIATION 19 0.0002
891 COLITIS ULCERATIVE 10 0.0002
892 JAUNDICE 6 0.0002
893 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
894 INJECTION SITE SWELLING 17 0.0002
895 PNEUMONITIS 6 0.0002
896 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
897 RESTLESSNESS 8 0.0002
898 AGITATION 16 0.0002
899 DRY SKIN 29 0.0002
900 ANAPHYLACTIC REACTION 12 0.0002
901 BLOOD GLUCOSE ABNORMAL 4 0.0002
902 IRRITABILITY 13 0.0002
903 THERAPEUTIC RESPONSE DECREASED 13 0.0002
904 HEPATIC FUNCTION ABNORMAL 8 0.0002
905 NERVOUSNESS 11 0.0002
906 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
907 SKIN DISORDER 7 0.0002
908 DRUG PRESCRIBING ERROR 4 0.0002
909 PANCREATIC CARCINOMA 6 0.0002
910 HYPOGLYCAEMIA 10 0.0002
911 NEUTROPENIA 28 0.0002
912 CEREBRAL INFARCTION 5 0.0002
913 DRUG EFFECT DECREASED 11 0.0002
914 GASTRIC DISORDER 7 0.0002
915 ACUTE MYOCARDIAL INFARCTION 6 0.0002
916 PSYCHOTIC DISORDER 6 0.0002
917 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
918 INJECTION SITE ERYTHEMA 25 0.0002
919 INJECTION SITE BRUISING 16 0.0002
920 PNEUMONIA ASPIRATION 5 0.0002
921 INJECTION SITE PAIN 61 0.0002
922 INTENTIONAL SELF-INJURY 4 0.0002
923 EPILEPSY 6 0.0002
924 PRODUCT ADHESION ISSUE 7 0.0002
925 INJECTION SITE WARMTH 4 0.0002
926 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 39 0.0002
927 DERMATITIS 4 0.0002
928 TOXICITY TO VARIOUS AGENTS 32 0.0002
929 FEAR 5 0.0002
930 DEVICE LEAKAGE 8 0.0002
931 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
932 OSTEONECROSIS 6 0.0002
933 EXPIRED PRODUCT ADMINISTERED 6 0.0002
934 INJECTION SITE PRURITUS 12 0.0002
935 WOUND 5 0.0002
936 UNDERDOSE 13 0.0002
937 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
938 CEREBROVASCULAR ACCIDENT 30 0.0002
939 EXTRA DOSE ADMINISTERED 7 0.0002
940 CARDIAC DISORDER 16 0.0002
941 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
942 CEREBRAL HAEMORRHAGE 6 0.0002
943 HEPATIC FAILURE 5 0.0002
944 FEBRILE NEUTROPENIA 11 0.0002
945 INTERSTITIAL LUNG DISEASE 8 0.0002
946 DRUG EFFECT INCOMPLETE 6 0.0002
947 MENTAL IMPAIRMENT 4 0.0002
948 LIVER INJURY 4 0.0002
949 DRUG ADMINISTRATION ERROR 5 0.0002
950 ADVERSE EVENT 15 0.0002
951 ABASIA 4 0.0002
952 DEVICE DISLOCATION 7 0.0002
953 DISEASE PROGRESSION 19 0.0002
954 MULTIPLE SCLEROSIS RELAPSE 11 0.0002
955 NERVOUS SYSTEM DISORDER 5 0.0002
956 DEATH 138 0.0002
957 CARDIAC ARREST 13 0.0002
958 ADVERSE DRUG REACTION 14 0.0002
959 ERECTILE DYSFUNCTION 4 0.0002
960 THERAPY NON-RESPONDER 7 0.0002
961 ANAPHYLACTIC SHOCK 4 0.0002
962 ABNORMAL BEHAVIOUR 6 0.0002
963 PROSTATE CANCER 12 0.0001
964 RENAL CANCER 7 0.0001
965 MULTIPLE SCLEROSIS 7 0.0001
966 MATERNAL EXPOSURE DURING PREGNANCY 13 0.0001
967 RHABDOMYOLYSIS 6 0.0001
968 NEOPLASM PROGRESSION 5 0.0001
969 HAEMORRHAGE 15 0.0001
970 WITHDRAWAL SYNDROME 6 0.0001
971 LIVER FUNCTION TEST ABNORMAL 4 0.0001
972 ECZEMA 7 0.0001
973 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
974 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
975 ACNE 10 0.0001
976 LUNG DISORDER 6 0.0001
977 CARDIO-RESPIRATORY ARREST 5 0.0001
978 INJECTION SITE REACTION 8 0.0001
979 DERMATITIS ATOPIC 6 0.0001
980 OVERDOSE 24 0.0001
981 NO ADVERSE EVENT 19 0.0001
982 PRODUCT STORAGE ERROR 9 0.0001
983 SKIN BURNING SENSATION 7 0.0001
984 ANGIOEDEMA 4 0.0001
985 MEDICATION ERROR 5 0.0001
986 SUICIDE ATTEMPT 5 0.0001
987 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
988 BREAST CANCER 6 0.0001
989 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
990 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
991 COMPLETED SUICIDE 4 0.0000